Triatomic Management’s Dillards DDS Stock Holding History

Triatomic Management’s Portfolio DDS Stock Details DDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,000	Closed	-$245K	–	43
2021 Q4	$245K	Buy	+1,000	New	+$263K	0.15%	34

Other funds holding DDS

Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CWM

ClientFirst Wealth Management Little Rock, Arkansas $118M AUM 40.43% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Triatomic Management's DDS Position: Q1 2022 in Review

Triatomic Management sold out of Dillards (DDS) in Q1 2022, closing a stake of 1,000 shares — an estimated $245K sold.

Triatomic Management first reported a position in DDS in Q4 2021 and held it in 1 quarter. The position peaked at $245K in Q4 2021. 224 funds tracked by Wall St. Rank hold DDS as of Q1 2022.

Triatomic Management reported no remaining Dillards position as of Q1 2022 after selling out during the quarter.
Triatomic Management sold 1,000 Dillards shares in Q1 2022, an estimated $245K.
Triatomic Management first reported a position in Dillards in Q4 2021 and held it in 1 quarter.
Triatomic Management's Dillards position peaked at $245K in Q4 2021.
224 funds tracked by Wall St. Rank held Dillards as of Q1 2022.

Based on Triatomic Management's 13F filing for Q1 2022, filed 12 May 2022.